LadRx Corporation | Evaluate

Biogen leads the way in renewed amyotrophic lateral sclerosis push

The company has quietly emerged as the key player to watch in an area that has seen several setbacks of late.

Asco event analyser – Puma investors’ Aphinity for Roche data

April 11, 2017

Calling time on biotech’s shady stock-promotion schemes

The US regulator has come down surprisingly hard on biotech stock promotion schemes.

July 15, 2016

Snippet roundup: Immuno-oncology hopes for Parkinson's class, Coherus climbs

March 17, 2016

Revisiting a predictor of failure in the post-Celator world

March 04, 2016

Upcoming events – Mast hopes for Epic success and Xadago faces US judgement

December 08, 2015

Sarcoma field digests evofosfamide failure

June 03, 2015

Asco Event Analyzer – 2015’s winners and losers

April 08, 2015

Therapy focus – Potential for progress in mesothelioma is on the horizon

June 05, 2014

Asco Event Analyzer – 2014’s winners and losers

April 08, 2014

Winners outweigh losers as small caps enjoy Q1's bull market

Load More